
Citizens JMP has reduced its price target on Wix.com (WIX) to $160 from $250, attributing the cut to increased investments in Base44 that are expected to impact operating income, and revising its 2026E free cash flow multiple to 15x from 23x. This adjustment, despite Wix's recent Q2 results exceeding revenue and FCF estimates, highlights a mixed analyst outlook; while some firms share growth and margin concerns, others maintain higher price targets, emphasizing strong fundamentals, monetization strategies, and new product potential.
Wix.com presents a case of conflicting signals, with a significant price target reduction by Citizens JMP to $160 from $250 creating a negative headline. This revision is explicitly tied to strategic investments in Base44, which are expected to pressure operating income and have led the firm to lower its valuation multiple to 15x 2026E free cash flow from a previous 23x. This bearish revision, however, contrasts with the company's recent operational performance, which saw Q2 revenue and free cash flow exceed estimates by 1% and 4% respectively, alongside 11% year-over-year bookings growth and a $15 million increase in full-year booking guidance. The analyst community is sharply divided, reflecting this dichotomy. While Cantor Fitzgerald and UBS also lowered targets due to growth and margin concerns, Scotiabank, Raymond James, and Benchmark maintain highly positive outlooks with price targets ranging from $230 to $255, citing strong fundamentals, new product momentum, and promising AI-led monetization strategies. The company's underlying financial health, evidenced by a 68% gross profit margin and 13% revenue growth in the last twelve months, provides a solid foundation that supports the more bullish theses.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.05
Ticker Sentiment